Literature DB >> 30765449

Atypical anaplastic astrocytoma with unique molecular features and diffuse leptomeningeal spread in a child with long-term survival.

Yasmin Aghajan1, Denise M Malicki2, Michael L Levy3, John Ross Crawford4.   

Abstract

Paediatric high-grade gliomas, including glioblastoma and anaplastic astrocytoma, make up 8%-12% of paediatric central nervous system tumours 1 and have poor prognosis, with 2-year survival less than 30% 2 and overall survival less than 10%. The only known prognostic factors in this population include extent of resection and tumour histological grade. We present the case of a 9-year-old boy with disseminated anaplastic astrocytoma treated with subtotal resection, craniospinal radiation and temozolomide, with 8-year survival despite metastatic disease at presentation and subtotal resection. Next generation cancer gene panel sequencing revealed an usual pattern of 12 amplifications and four mutations not previously described. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cns cancer; neurooncology; paediatric oncology

Mesh:

Substances:

Year:  2019        PMID: 30765449      PMCID: PMC6381959          DOI: 10.1136/bcr-2018-228153

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

1.  Temozolomide for pediatric high-grade gliomas.

Authors:  Roger J Packer
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

2.  A common 8q (MYC) amplification detected in a multifocal anaplastic astrocytoma by SNP array karyotyping.

Authors:  Michelle Madden Felicella; Jill M Hagenkord; Shera F Kash; Martin P Powers; Mitchel S Berger; Arie Perry
Journal:  Clin Neuropathol       Date:  2012 Jul-Aug       Impact factor: 1.368

Review 3.  Molecular characteristics of pediatric high-grade gliomas.

Authors:  Omar Chamdine; Amar Gajjar
Journal:  CNS Oncol       Date:  2014-11

4.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

Authors:  Roger Stupp; Warren P Mason; Martin J van den Bent; Michael Weller; Barbara Fisher; Martin J B Taphoorn; Karl Belanger; Alba A Brandes; Christine Marosi; Ulrich Bogdahn; Jürgen Curschmann; Robert C Janzer; Samuel K Ludwin; Thierry Gorlia; Anouk Allgeier; Denis Lacombe; J Gregory Cairncross; Elizabeth Eisenhauer; René O Mirimanoff
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

5.  Prognosis of pediatric high-grade gliomas with temozolomide treatment: a retrospective, multicenter study.

Authors:  Tae-Young Jung; Chae-Yong Kim; Dong-Seok Kim; Young-Shin Ra; Seong-Ho Kim; Hee-Jo Baek; Hyoung-Soo Choi; In-Ah Kim
Journal:  Childs Nerv Syst       Date:  2012-05-11       Impact factor: 1.475

  5 in total
  2 in total

Review 1.  Patients' Survival with Astrocytoma After Treatment: a Systematic Review and Meta-analysis of Clinical Trial Studies.

Authors:  Nader Salari; Reza Fatahian; Mohsen Kazeminia; Amin Hosseinian-Far; Shamarina Shohaimi; Masoud Mohammadi
Journal:  Indian J Surg Oncol       Date:  2022-04-25

2.  Comprehensive metabolomics study on the pathogenesis of anaplastic astrocytoma via UPLC-Q/TOF-MS.

Authors:  Chao Du; Zhehao Huang; Bo Wei; Miao Li
Journal:  Medicine (Baltimore)       Date:  2022-08-05       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.